These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16341811)
1. Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation. Baser ME; Rai H; Wallace AJ; Evans DG Fam Cancer; 2005; 4(4):321-2. PubMed ID: 16341811 [TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224 [TBL] [Abstract][Full Text] [Related]
4. A mouse model recapitulating molecular features of human mesothelioma. Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma. Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813 [TBL] [Abstract][Full Text] [Related]
6. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Bianchi AB; Mitsunaga SI; Cheng JQ; Klein WM; Jhanwar SC; Seizinger B; Kley N; Klein-Szanto AJ; Testa JR Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10854-8. PubMed ID: 7479897 [TBL] [Abstract][Full Text] [Related]
7. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC Oncogene; 2003 Jun; 22(24):3799-805. PubMed ID: 12802287 [TBL] [Abstract][Full Text] [Related]
8. Multiple meningiomas: differential involvement of the NF2 gene in children and adults. Evans DG; Watson C; King A; Wallace AJ; Baser ME J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074 [TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Sekido Y; Pass HI; Bader S; Mew DJ; Christman MF; Gazdar AF; Minna JD Cancer Res; 1995 Mar; 55(6):1227-31. PubMed ID: 7882313 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function. Kley N; Whaley J; Seizinger BR Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465 [TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma. Glass C; Sholl LM; Landgraf JR; Chirieac L; Roggli VL Am J Surg Pathol; 2020 Feb; 44(2):288-292. PubMed ID: 31567203 [TBL] [Abstract][Full Text] [Related]
12. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107 [TBL] [Abstract][Full Text] [Related]
13. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Jacoby LB; MacCollin M; Parry DM; Kluwe L; Lynch J; Jones D; Gusella JF Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886 [TBL] [Abstract][Full Text] [Related]
14. Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2. Dinh CT; Nisenbaum E; Chyou D; Misztal C; Yan D; Mittal R; Young J; Tekin M; Telischi F; Fernandez-Valle C; Liu XZ Otol Neurotol; 2020 Jun; 41(5):e529-e537. PubMed ID: 32150022 [TBL] [Abstract][Full Text] [Related]
15. Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region. Pylkkänen L; Sainio M; Ollikainen T; Mattson K; Nordling S; Carpén O; Linnainmaa K; Husgafvel-Pursiainen K Oncol Rep; 2002; 9(5):955-9. PubMed ID: 12168054 [TBL] [Abstract][Full Text] [Related]
16. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome? Kley N; Seizinger BR Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520 [TBL] [Abstract][Full Text] [Related]
17. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene. Baser ME; Hum Mutat; 2006 Apr; 27(4):297-306. PubMed ID: 16521120 [TBL] [Abstract][Full Text] [Related]
18. In Silico Analysis of NF2 Gene Missense Mutations in Neurofibromatosis Type 2: From Genotype to Phenotype. Heineman TE; Evans DG; Campagne F; Selesnick SH Otol Neurotol; 2015 Jun; 36(5):908-14. PubMed ID: 25931164 [TBL] [Abstract][Full Text] [Related]